Member Info for Ghia

I understand completely the desire to let StemPrintER flourish as it's own entity, it's reached the point that it's ready to fly the nest so to speak and TILS wants to prevent the other eggs getting knocked to the ground.

They must value highly some of the other eggs in the nest.

Can only see this being a good thing for those invested prior to the yet to be announce cutoff date.

I would have liked to see NASDAQ for the new spinoff instead of LSE because I would have thought it would be valued higher on their but nevermind.

I guess TILS will drop in the short term once the split happens, dependant on news flow about the other opportunities.

Having been on the fence here for a while todays news tipped the balance for me and i'm now in for a small amount.

I guess that's the price you pay for only ever borrowing your shares and not properly owning them.

Assuming the new company will be listed on NASDAQ which is most likely, would I have to hold shares in a broker account that allows me to deal on that exchange or could I receive new shares as a share certificate and open a new broker account.

It will be interesting to see how much of the future sales have been priced into the current mcap by the market.

We will only find this out once the sales RNS’s start rolling in.

Interesting times ahead I’m not sure what to expect but certainly rather be in than out.

I think there is a lot of money being thrown at all Covid plays currently. Most of this is not “sticky money” rather “fast and hot money”

The recents gains on AVCT and probable gains short term on some of the other Covid plays should benefit us as our “Hot Period” does not seem to be coinciding with others.

If prior to results we are not north of our 70p highs I will be genuinely peeved for those holders that have waited it out from those levels.

Had it not been for lansdowne we would likely not be at these levels however as June draws nearer we will see the speculators arrive, the hot money move in and the buzz return, (probably to the detriment of the bb).

So enjoy a few weeks of normality, debate and stellar research and then brace yourself for a tsunami of ramping, games and new overnight experts.

I took the day off today glad to see a bit of blue!

I think you will realise a better return on SNG than you will on TILS over the next 6months.

This prediction could come back to bite me. But I feel the next few months is SNG’s moment.

Nolupus- That’s why I asked you directly, I think you have the right idea to measure for the interferon signature to decide on the appropriate treatment, I think you referred to it as fine tuning the interferon levels.

I’ve read somewhere that serious cases of Covid can result in lasting damage to the lungs in this cases perhaps they will need careful management of their interferon signature long term.

Nolupus - Have you read much into project DRAGON? I’m wondering if the outcome of that project would be to fingerprint amongst other things the interferon signature of the patient thus deciding the appropriate intervention and dosage required?

There is more risk here but the potential upside is also vast.

My average here is mid to low 50’s frustrating that the price has traded sideways in generalised terms but feel fortunate I made a staged entry, I’ve bought some in the 60’s.

Probably the best advice I was given about investing was to split your investment into several chunks and enter over a period of time.

Miggy - I was in there at 26 mostly out at 1.70 before the placing news. Only stock I’ve timed reasonably well lately. Been dipping back in on the back of the drop due to placing.

SNG is my largest Covid play by far.

And a cross ramp to boot what has gotten into you Miggy!!

Your portfolio is looking a lot like mine.

Subtle de-ramp by Miggy… I think it's safe to assume he meant support.

I'm still expecting an RNS to state that the trial is filled and 100 patients have finished treatment.

As mentioned previously end of dosage period is 14days, but there is a 14day follow up period. Whilst I expect the last patient is receiving their last dose at some point this week, we may have to wait a further 2weeks until the trial is officially completed.

Other factors I have seen posted on ADVFN are that they may have to recruit a couple of extra patients incase some of the patient data fails validation, I believe the data validation can happen in a blinded fashion. Thinking scenarios such as contaminated samples missing data entry etc.

Just a little more patience required don't be concerned that we have not heard anything yet.

I’ve stopped accumulating here and have put a large-ish speculative limit order in at 48p valid for 5weeks.

I have no justification for the price whatsoever other than that AIM continuously surprises me.

Games will be played before results hit, judging by the form so far the company is a very tight ship so don’t believe anything until the RNS lands.

His story seems to be at odds with the trial criteria.

It reads as if he started taking SNG001 after he had recovered from his fever.

However the NIHR have said he was on the trial so he is/was.

It’s nice to hear the positive stories rather than all the negatives.

ShareSting- I agree that it looks like Lansdowne are still offloading.

I had thought they where closer to 10% when they released the last TR1 so I’ve given up trying to track it too closely. But would have thought we should see something this week TR1 wise.

25p and 44p you should be pleased with those entry points.

I have the kitchen sink on standby for any last minute wobbles.

I think the fund raise was prudent if they get the right result from phase 2 they will want to keep the momentum going.

Better to go into negotiations with plenty of cash, if they try and low ball us we probably have funding to roll out our own phase 3.

Obviously better to partner up license etc but don’t want to be seen as desperate.